… TMB variability across solid tumors with implications for cutoff selection, its association with
benefit from ICIs, and strategies to optimize TMB as a predictive biomarker for ICIs in clinical …

… biomarker was independent of other putative biomarkers, we compared ctDNA B and ∆ctDNA
C3 with tumor … Only two of 94 patients had microsatellite instability high (MSI-H) tumors (…

… tumor and phenotype activation status) could become a central biomarker that is predictive
for … of the prognostic and predictive roles of the immune infiltrate in cancer patients and (ii) the …

… responses in some patients with low levels … predictive biomarker. An improved understanding
of the host immune system and tumor microenvironment will better elucidate which patients …

… paradigms across multiple tumor types. However, only a subset of patients treated with …
requires additional predictive biomarkers that further establish which patients are most likely …

… in patients receiving prior … patients with hormone-sensitive prostate cancer, undergoing
therapy for HSPC at our institution. A univariate analysis of potential predictive biomarkers …

… proliferation and apoptosis in the tumor upon delivery of a drug, … , predictive biomarkers
assess the likelihood that the tumor … There are a small number of predictive biomarkers that have …

… L1 IHC biomarker. PD-L1 IHC and TMB are currently the two best predictive biomarkers that
… treatment decisions in advanced or metastatic NSCLC patients. The aim of this review is to …

… may become both a prognostic and a predictive biomarker. An analysis of over 600 miRNAs
from tumor tissues derived from patients with bladder cancer treated with cisplatin allowed …

… Mutations in KRAS are the only established predictive markers for selecting treatment
strategies in CRC. Patients with tumors harboring mutations in codon 12 or 13 of the KRAS gene …